Cannabis and Sexual Health: Evidence and Clinical Considerations

Endocannabinoid System and Sexual Function

• Endocannabinoid receptors are expressed in reproductive tissues and relevant brain regions
• The endocannabinoid system modulates sexual arousal, desire, and physiological responses
• Anandamide levels fluctuate in relation to sexual activity and arousal states
• Endocannabinoid tone influences both central and peripheral aspects of sexual function

The endocannabinoid system’s involvement in sexual health is an emerging area of research that intersects pharmacology, psychology, and reproductive medicine. Endocannabinoid receptors are present throughout the reproductive system and in brain regions associated with sexual desire and arousal. Understanding how cannabis interacts with this system is increasingly relevant as patient populations on medical cannabis include those with conditions affecting sexual function.

Cannabis and Sexual Dysfunction

• Some patients report cannabis use associated with improved sexual function and reduced anxiety around intimacy
• High-dose THC may impair sexual function in some individuals, particularly with chronic heavy use
• Cannabis-related anxiolytic effects may reduce performance anxiety in some patients
• The evidence base is largely based on patient self-report rather than controlled clinical trials

Reports from medical cannabis patients frequently include references to effects on sexual function, both positive and negative. The heterogeneity of these reports reflects the complexity of sexual function, the diversity of cannabis preparations used, and individual variability in response. Clinicians should feel comfortable enquiring about sexual health as part of a comprehensive review of a patient’s response to cannabis treatment, without preconceptions about the direction of effect.

Pain, Menstrual Health, and Pelvic Conditions

• Medical cannabis has been explored as a treatment for chronic pelvic pain and dysmenorrhoea
• Endometriosis patients have reported symptom relief with cannabis use in observational studies
• Vulvodynia and vaginismus are conditions where some patients report benefit
• Cannabis-based topical preparations are being investigated for localised pelvic pain management

The application of medical cannabis to gynaecological and pelvic health conditions has generated considerable patient-led interest. Conditions characterised by chronic pain — endometriosis, dysmenorrhoea, pelvic floor dysfunction — overlap significantly with conditions where cannabis has demonstrated analgesic and anti-inflammatory effects. Whilst randomised controlled trial evidence in these specific conditions is limited, observational data and mechanistic plausibility support continued clinical research.

HIV and Sexual Health Comorbidities

• Medical cannabis has established utility in managing HIV-associated symptoms including nausea and pain
• HIV-associated sexual dysfunction may have multiple contributing factors including medication side effects
• Cannabis interactions with antiretroviral medications require careful clinical consideration
• Sexual health clinicians increasingly encounter patients using cannabis for symptom management

The intersection of medical cannabis and HIV care is particularly relevant given cannabis’s established role in managing HIV-associated symptoms. Sexual health clinicians working with HIV-positive patients may encounter complex questions about cannabis use — both self-initiated and prescribed — and its interaction with antiretroviral medications. Building familiarity with cannabis pharmacology and potential drug interactions is increasingly part of the sexual health clinician’s knowledge base.